MAPT and Alzheimer disease: 2013) suggesting that APP mutations are not sufficient to cause neuronal loss that is observed in human AD and models with tau abnormalities but in contrast with Huang et al. (2016) who reported a decrease (~20%) in NeuN staining and hippocampal atrophy (~20–30%).